Vivesto AB (VIVE.ST)
Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Erik Kinnman Assoc. Prof., M.B.A., M.D., Ph.D. | Chief Executive Officer | 4.7M | -- | 1958 |
| Mr. Robert Maiorana | Head of Accounting & Acting CFO | -- | -- | 1960 |
| Ms. Teresa Fernandez Zafra | Chief Scientific Officer & Head of Preclinical Development & Clinical Operations | -- | -- | 1987 |
| Mr. Urban Ekelund | IR Manager | -- | -- | -- |
| Mr. John T. Cosby | Head of Regulatory Affairs | -- | -- | 1962 |
| Mr. Dzianis Babrou | Head of Product Development | -- | -- | -- |
| Mr. Henrik Rönnberg | Chief Medical Officer of Animal Health | -- | -- | -- |
| Maria Nilsson Hagberg | Head of Regulatory Affairs | -- | -- | -- |
| Dr. Heidi B. Ramstad | Chief Medical Officer | -- | -- | 1969 |
| Ms. Johanna Rostin | Chief Regulatory Officer | -- | -- | 1967 |
Vivesto AB
- Sector:
- Healthcare
- Industry: Drug Manufacturers - Specialty & Generic
- Full Time Employees:
- 4
Description
Vivesto AB develops, produces, markets, and sells drugs in the field of human and veterinary oncology in Sweden. Its lead product is Apealea (paclitaxel micellar) for the treatment of ovarian cancer. The company's products portfolio includes Docetaxel micellar, a patented formulation that combines cytotoxin docetaxel with XR-17, which is in Phase 1b clinical trial for the treatment of prostate cancer; and Cantrixil to treat ovarian cancer. its animal health product portfolio includes Paccal Vet, a formulation of paclitaxel with its XR-17 encapsulation technology for the treatment of canine mastocytoma; and Doxophos Vet, a patented formulation of doxorubicin to treat lymphoma. The company was formerly known as Oasmia Pharmaceutical AB (publ) and changed its name to Vivesto AB in March 2022. Vivesto AB was incorporated in 1988 and is headquartered in Solna, Sweden.
Corporate Governance
Upcoming Events
August 20, 2025 at 10:59 AM UTC - August 25, 2025 at 12:00 PM UTC
Vivesto AB Earnings Date
Recent Events
Recent Events Information Not Available